Inclusion of flavoring agents (aromatic syrups) and therapeutic active pharmaceutical ingredients (medicated syrups). 3. Clinical Context: Maple Syrup Urine Disease (MSUD)
Syrups are preferred for children under five due to ease of swallowing and dose flexibility. Sirap.AliEve.1.var
In the context of "AliEve.1," the E1 component (decarboxylase) is a critical part of the BCKDH enzyme complex involved in Maple Syrup Urine Disease (MSUD) . 2. Pharmaceutical Formulation (The ".var" Variables) Sirap.AliEve.1.var